From “Survivor” to Surviving Hodgkin Lymphoma: How Ethan Zohn’s Log Challenge Raises Cancer Awareness
Photo by Thomas Peham on Unsplash

From “Survivor” to Surviving Hodgkin Lymphoma: How Ethan Zohn’s Log Challenge Raises Cancer Awareness

  Growing up, my family and I faithfully watched Survivor each week. Although my parents stopped watching a few years back, settling in every Wednesday during the season is somewhat of a…

Continue Reading From “Survivor” to Surviving Hodgkin Lymphoma: How Ethan Zohn’s Log Challenge Raises Cancer Awareness
Experimental Treatment for Neuroblastoma Earns Rare Pediatric Disease Designation
source: pixabay.com

Experimental Treatment for Neuroblastoma Earns Rare Pediatric Disease Designation

According to a story from BioSpace, the radiopharmaceutical company Clarity Pharmaceuticals has recently announced that the US Food and Drug Administration (FDA) has granted Rare Pediatric Disease designation to its…

Continue Reading Experimental Treatment for Neuroblastoma Earns Rare Pediatric Disease Designation
FDA Approves a New Treatment for Non-Radiographic Axial Spondyloarthritis
source: pixabay.com

FDA Approves a New Treatment for Non-Radiographic Axial Spondyloarthritis

In a press release from Eli Lilly and Company, the company has announced recently that the US Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (BLA)…

Continue Reading FDA Approves a New Treatment for Non-Radiographic Axial Spondyloarthritis
Study: Nuplazid as a Treatment for Psychosis in Parkinson’s Disease Patients
source: pixabay.com

Study: Nuplazid as a Treatment for Psychosis in Parkinson’s Disease Patients

Acadia Pharmaceuticals recently released the results of their Phase 3 trial of Nuplazid, a treatment for the psychosis that Parkinson's disease patients experience. This medication has been approved since 2016,…

Continue Reading Study: Nuplazid as a Treatment for Psychosis in Parkinson’s Disease Patients